GENEVA (Reuters) - National supply deals in the event of the development of a successful vaccine against the coronavirus should fit a global approach, World Health Organization senior adviser Bruce Aylward said on Tuesday.
World leaders pledged in late April to accelerate work on tests, drugs and vaccines against COVID-19 and to share them around the globe under a WHO-led initiative known as the ACT (Access to COVID-19 Tools) Accelerator.
More than 21.9 million people have been reported to be infected by the novel coronavirus globally and 772,647 have died, according to a Reuters tally.
Reporting by Stephanie Nebehay, Michael Shields and John Miller; Writing by Nick Macfie; Editing by Jon Boyle
Our Standards: The Thomson Reuters Trust Principles.